21. Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy. (24th September 2021) Authors: Sasaki, Hiroshi; Miki, Kenta; Tashiro, Kojiro; Mori, Keiichiro; Urabe, Fumihiko; Fukuokaya, Wataru; Kimura, Takahiro; Sato, Shun; Takahashi, Hiroyuki; Aoki, Manabu; Egawa, Shin Journal: Andrology Issue: Volume 10:Number 2(2022) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Differential expression of androgen receptor variants in hormone‐sensitive prostate cancer xenografts, castration‐resistant sublines, and patient specimens according to the treatment sequence. Issue 9 (18th April 2019) Authors: Honda, Mariko; Kimura, Takahiro; Kamata, Yuko; Tashiro, Kojiro; Kimura, Shoji; Koike, Yusuke; Sato, Shun; Yorozu, Takashi; Furusato, Bungo; Takahashi, Hiroyuki; Kiyota, Hiroshi; Egawa, Shin Journal: Prostate Issue: Volume 79:Issue 9(2019) Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens. Issue 5 (May 2021) Authors: Mori, Keiichiro; Sharma, Vidit; Comperat, Eva M.; Sato, Shun; Laukhtina, Ekaterina; Schuettfort, Victor M.; Pradere, Benjamin; Parizi, Mehdi Kardoust; Karakiewicz, Pierre I.; Egawa, Shin; Tilki, Derya; Boorjian, Stephen A.; Shariat, Shahrokh F. Journal: European journal of surgical oncology Issue: Volume 47:Issue 5(2021) Page Start: 1172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Do androgen deprivation and the biologically equivalent dose matter in low‐dose‐rate brachytherapy for intermediate‐risk prostate cancer?. (25th July 2016) Authors: Tabata, Ryuji; Kimura, Takahiro; Kuruma, Hidetoshi; Sasaki, Hiroshi; Kido, Masahito; Miki, Kenta; Takahashi, Hiroyuki; Aoki, Manabu; Egawa, Shin Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?. (13th May 2022) Authors: Yanagisawa, Takafumi; Sato, Shun; Hayashida, Yasushi; Okada, Yohei; Iwatani, Kosuke; Matsukawa, Akihiro; Kimura, Takahiro; Takahashi, Hiroyuki; Egawa, Shin; Shariat, Shahrokh F.; Miki, Jun Journal: BJU international Issue: Volume 131:Number 2(2023) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer. Issue 14 (29th June 2022) Authors: Yanagisawa, Takafumi; Kimura, Takahiro; Hata, Kenichi; Narita, Shintaro; Hatakeyama, Shingo; Enei, Yuki; Atsuta, Mahito; Mori, Keiichiro; Obayashi, Koki; Yoshihara, Kentaro; Kondo, Yosuke; Oguchi, Takahiro; Sadakane, Ibuki; Habuchi, Tomonori; Ohyama, Chikara; Shariat, Shahrokh F.; Egawa, Shin Journal: Prostate Issue: Volume 82:Issue 14(2022) Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Does docetaxel prolong survival of patients with non‐metastatic castration‐resistant prostate cancer?. Issue 7 (23rd February 2018) Authors: Ito, Kagenori; Kimura, Takahiro; Onuma, Hajime; Tabata, Ryuji; Shimomura, Tatsuya; Miki, Kenta; Tomita, Masayuki; Egawa, Shin Journal: Prostate Issue: Volume 78:Issue 7(2018) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Earlier use of androgen receptor‐axis‐targeted drugs may improve overall survival in patients with non‐metastatic castration‐resistant prostate cancer. Issue 10 (10th April 2018) Authors: Mori, Keiichiro; Kimura, Takahiro; Ito, Kagenori; Onuma, Hajime; Tanaka, Masatoshi; Matsuura, Taishi; Kurokawa, Gaku; Iwatani, Kosuke; Inaba, Yuzo; Sakanaka, Keigo; Sasaki, Hiroshi; Miki, Jun; Shimomura, Tatsuya; Miki, Kenta; Egawa, Shin Journal: Prostate Issue: Volume 78:Issue 10(2018) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study. Issue 13 (23rd June 2022) Authors: Miura, Yuki; Hatakeyama, Shingo; Narita, Shintaro; Kimura, Takahiro; Hata, Kenichi; Yanagisawa, Takafumi; Tanaka, Toshikazu; Ishi, Noritaka; Kawamura, Sadafumi; Hoshi, Senji; Ishidoya, Shigeto; Mitsuzuka, Koji; Ito, Akihiro; Tsuchiya, Norihiko; Egawa, Shin; Habuchi, Tomonori; Ohyama, Chikara Journal: Prostate Issue: Volume 82:Issue 13(2022) Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer. Issue 1 (17th January 2022) Authors: Nishimura, Kazuki; Nishio, Kyosuke; Hirosuna, Kensuke; Komura, Kazumasa; Hayashi, Takuo; Fukuokaya, Wataru; Ura, Ayako; Uchimoto, Taizo; Nakamura, Ko; Fukushima, Tatsuo; Yano, Yusuke; Takahashi, Nobushige; Nakamori, Keita; Kinoshita, Shoko; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya;... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗